Dr. Vanholder has published more than 900 papers, including reviews and book chapters, on the adequacy of dialysis, uremic toxicity, and various topics related to clinical nephrology. He serves as a member of the editorial review board of several journals and is subject editor of  Nephrology Dialysis and Transplantation and Toxins. Up until autumn 2010, he was chairman of the European Uremic Toxin Work Group (EUTox) and member of the Executive Board, and treasurer of Kidney Disease Improving Global Outcomes (KDIGO). Up till summer 2011, he was a member of the Scientific Advisory Board (SAB) of the European Renal Association – European Dialysis and Transplantation Association (ERA-EDTA) and chairman of the European Renal Best Practice (ERBP), the guidance body of ERA-EDTA.  Before that, he coordinated the European Best Practice Guidelines (EBPG) on hemodialysis.  He has chaired the Renal Disaster Relief Task Force (RDRTF) of the International Society of Nephrology (ISN) till the end of 2014 and in this function participated as a member or coordinator in several international relief operations. Dr. Vanholder was the founding president of the Belgian Society of Nephrology (BVN-SBN), is past president of the European Society of Artificial Organs (ESAO), and of ERA-EDTA. He is currently the chairman of the European Kidney Health Alliance (EKHA) and from January 1 2017 also of European Chronic Disease Alliance (ECDA). His main interest has been Identification,